1. Academic Validation
  2. Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF

Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF

  • EMBO J. 2002 Dec 16;21(24):6811-9. doi: 10.1093/emboj/cdf669.
Vanessa Brès 1 Hideaki Tagami Jean-Marie Péloponèse Erwan Loret Kuan-Teh Jeang Yoshihiro Nakatani Stephane Emiliani Monsef Benkirane Rosemary E Kiernan
Affiliations

Affiliation

  • 1 Laboratoire de Virologie Moléculaire et Transfert de Gène, Institut de Génétique Humaine, CNRS UPR1142, Montpellier, France.
Abstract

The HIV-1 transactivator protein, Tat, is an atypical transcriptional activator that functions through binding, not to DNA, but to a short leader RNA, TAR. Although details of its functional mechanism are still unknown, emerging findings suggest that Tat serves primarily to adapt co-activator complexes such as p300, PCAF and P-TEFb to the HIV-1 long terminal repeat. Hence, an understanding of how Tat interacts with these cofactors is crucial. It has recently been shown that acetylation at a single lysine, residue 50, regulated the association of Tat with PCAF. Here, we report that in the absence of Tat acetylation, PCAF binds to Amino acids 20-40 within Tat. Interestingly, acetylation of Tat at Lys28 abrogates Tat-PCAF interaction. Acetylation at Lys50 creates a new site for binding to PCAF and dictates the formation of a ternary complex of Tat-PCAF-P-TEFb. Thus, differential lysine acetylation of Tat coordinates the interactions with its co-activators, cyclin T1 and PCAF. Our results may help in understanding the ordered recruitment of Tat co-activators to the HIV-1 promoter.

Figures